Teruhisa Azuma1, Yoshihiro Nozawa2 (1.Shirakawa Satellite for Teaching And Research in General Medicine, Japan, 2.Shirakawa Kosei General Hospital, Shirakawa city, Japan)
Session information
Oral Session
Oral Session 2-7D Malignant Lymphoma: Pathophysiology/Others
Sat. Oct 13, 2018 4:00 PM - 5:00 PM No.7 (Osaka International Convention Center, 10F 1001)
Chair: Tomomi Toubai (Department of Internal Medicine Ⅲ Division of Hematology Cell Therapy,Yamagata University Faculty of Medicine, Japan)
Yoshiaki Okano1, Tatsuo Oyake1, Akihiro Otsu1, Tadashi Shimoyama1, Maki Nishiya1, Norifumi Sugawara1, Wataru Izumita1, Yasuhiko Tsukushi1, Shugo Kowata1, Kenji Shimosegawa2, Takashi Ishida1 (1.Iwate Medical University, Division of Hematology and Oncology, Morioka, Japan, 2.Iwate Prefectural Chubu Hospital, Division of Hematology,,kitakami, Japan)
Junichi Kitagawa1, Yuto Kaneda1, Takuro Matsumoto1, Yuhei Shibata2, Nobuhiko Nakamura1, Hiroshi Nakamura1, Soranobu Ninomiya1, Masahito Shimizu1, Takeshi Hara1,3, Hisashi Tsurumi1,3 (1.Hematol., Gifu Univ., Gifu, Japan, 2.Hematol., Gifu Muni. Hosp., Gifu, Japan, 3.Hematol., Matsunami General Hosp., Gifu, Japan)
Yumi Ishiguri, Norihiro Ueda, Rika Kihara, Koichi Watamoto (Hematol., Komaki City Hospital, Aichi, Japan)
Daisuke Niino1, Luong Thi My Hanh2, Shiro Miura3, Masahiro Nakashima2, Masako Iwanaga4 (1.Nagasaki Educational-Diagnostic Center of Pathology, Nagasaki Univ, Nagasaki, Japan, 2.Tumor/Diagnostic Pathology, A-Bomb Dis Inst, Nagasaki Univ, Nagasaki, Japan, 3.Tissue/Histopathology Section, A-Bomb Dis Inst, Nagasaki Univ, Nagasaki, Japan, 4.Frontier Life Science, Nagasaki Univ Grad School Biomed, Nagasaki, Japan)
Hirotaka Nakamura, Hitomi Kaneko, Tomohiro Taya, Ryosuke Nomura, Takaya Mitsuyoshi, Kohei Tada, Masaharu Tashima, Kazuo Hatanaka, Chisato Mizutani, Kazunori Imada (Osaka Red Cross hospital)